119 related articles for article (PubMed ID: 8210844)
1. [Dermatological treatment and pregnancy].
Piérard-Franchimont C; Gérardy-Goffin F; Piérard GE
Rev Med Liege; 1993 Sep; 48(9):505-11. PubMed ID: 8210844
[No Abstract] [Full Text] [Related]
2. Oral isotretinoin and pregnancy prevention programmes.
Thiboutot D; Gollnick H; Bettoli V; Dréno B; Kang S; Leyden JJ; Shalita A; Torres V;
Br J Dermatol; 2012 Feb; 166(2):466-7; author reply 467-8. PubMed ID: 21985025
[No Abstract] [Full Text] [Related]
3. A practical guide to dermatological drug use in pregnancy.
Zip C
Skin Therapy Lett; 2006 May; 11(4):1-4. PubMed ID: 16732394
[TBL] [Abstract][Full Text] [Related]
4. An opportunity for improvement: iPLEDGE policy changes during the coronavirus pandemic.
Pathoulas JT; Farah RS; Fiessinger L; Mansh M
Dermatol Ther; 2020 Nov; 33(6):e14411. PubMed ID: 33052629
[No Abstract] [Full Text] [Related]
5. Was the thalidomide tragedy preventable?
Smithells D
Lancet; 1998 May; 351(9115):1591. PubMed ID: 10326577
[No Abstract] [Full Text] [Related]
6. [Gold therapy and pregnancy].
Fuchs U; Lippert TH
Dtsch Med Wochenschr; 1986 Jan; 111(1):31-4. PubMed ID: 3079697
[No Abstract] [Full Text] [Related]
7. [When are drugs in pregnancy indicated and when contraindicated?].
Loch EG; Kaiser E
Z Allgemeinmed; 1975 May; 51(13):595-9. PubMed ID: 1216893
[No Abstract] [Full Text] [Related]
8. Reduction in frequency of fetopathic effects of caffeine in mice by pretreatment with propranolol.
Fujii T; Nishimura H
Teratology; 1974 Oct; 10(2):149-52. PubMed ID: 4473845
[No Abstract] [Full Text] [Related]
9. Ethical challenges of pregnancy prevention programs.
Bonebrake R; Casey MJ; Huerter C; Ngo B; O'Brien R; Rendell M
Cutis; 2008 Jun; 81(6):494-500. PubMed ID: 18666392
[TBL] [Abstract][Full Text] [Related]
10. Teratogenicity of isotretinoin revisited: species variation and the role of all-trans-retinoic acid.
Nau H
J Am Acad Dermatol; 2001 Nov; 45(5):S183-7. PubMed ID: 11606951
[TBL] [Abstract][Full Text] [Related]
11. The value of animal teratogenicity testing for predicting human risk.
Brown NA; Fabro S
Clin Obstet Gynecol; 1983 Jun; 26(2):467-77. PubMed ID: 6851294
[No Abstract] [Full Text] [Related]
12. Caring for women with childbearing potential taking teratogenic dermatologic drugs. Guidelines for practice.
Perlman SE; Rudy SJ; Pinto C; Townsend-Akpan C
J Reprod Med; 2001 Feb; 46(2 Suppl):153-61. PubMed ID: 11255823
[TBL] [Abstract][Full Text] [Related]
13. [Teratogens].
Julián M
Rev Chil Pediatr; 1988; 59 Suppl 3():9-12. PubMed ID: 3271376
[No Abstract] [Full Text] [Related]
14. [30 years with isotretinoin. "Miracle medicine" against acne with many side effects].
Mobacken H; Sundström A; Vahlquist A
Lakartidningen; 2014 Jan 15-28; 111(3-4):93-6. PubMed ID: 24552013
[No Abstract] [Full Text] [Related]
15. A survey of pregnant women using isotretinoin.
Robertson J; Polifka JE; Avner M; Chambers C; Delevan G; Koren G; Lavigne SV; Martinez LP; Miller RK; Carey JC
Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):881-7. PubMed ID: 16228976
[TBL] [Abstract][Full Text] [Related]
16. [Function of maternal immune-system and the embryonic sensitivity to teratogens].
Fein A; Torchinsky A; Toder V
Harefuah; 1998 Feb; 134(3):198-200. PubMed ID: 9662912
[No Abstract] [Full Text] [Related]
17. Protecting the unborn: Dow's experience.
Rao KS; Schwetz BA
Occup Health Saf; 1981 Mar; 50(3):53-6, 58-61. PubMed ID: 6782529
[No Abstract] [Full Text] [Related]
18. The need for restricted prescription of retinoic acid derivative isotretinoin to prevent retinoid teratogenicity.
De Santis M; Straface G; Cavaliere A; Nobili E; Caruso A
Prev Med; 2007; 45(2-3):243-4. PubMed ID: 17640721
[No Abstract] [Full Text] [Related]
19. Patient-physician-regulator triad.
Valois M; Peterson R; Bouthillier L
CMAJ; 2005 Jan; 172(1):15; author reply 18. PubMed ID: 15632390
[No Abstract] [Full Text] [Related]
20. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
Schaefer C; Meister R; Weber-Schoendorfer C
Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
